<DOC>
	<DOC>NCT01891604</DOC>
	<brief_summary>Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm infants' health, and may also play a role in reducing NEC and associated morbidity.</brief_summary>
	<brief_title>Study the Safety and Efficacy of Probiotics Use in Premature Infants</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Infant, Premature, Diseases</mesh_term>
	<criteria>born with weightï¼œ1500 g hospitalized within 48 hours after birth present with evidence or suspicion of congenital intestinal obstruction perforation gastroschisis large omphalocele congenital diaphragmatic hernia major congenital heart defects</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Days</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>